Seletracetam not checked

UCB Pharma SA

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
2 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“* Pharmaceutical form: oral capsules * Concentration: 10 and 50 mg * Route of administration: oral administration”In the company’s words, NCT00152451 on ClinicalTrials.gov
Tested for
Epilepsy, Partial (2 trials)
Main trialPhase 2
“This trial will evaluate the efficacy and safety of ucb 44212 as add on therapy in subjects with focal epilepsy.”In the company’s words, NCT00152451 on ClinicalTrials.gov

Other drugs for Epilepsy, Partial

All 9 drugs for Epilepsy, Partial

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 2Completed 3 May 2006 Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures
Phase 2Completed 12 May 2006 Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Seletracetam

Following is part of Solo: you see every change to Seletracetam the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in